July 14, 2014 4:16 PM | 2 min read
27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
TearLab Corporation (Nasdaq: TEAR) (TSX:TLB) ("TearLab" or the "Company") today announced the appointment of Manoj S. Venkiteshwar, PhD. to its senior management team in the newly created position of Vice President of Medical Affairs.Dr. Venkiteshwar's mandate will be the development and execution of a comprehensive academic and KOL management strategy for the Company.Dr. Venkiteshwar brings a wealth of international ophthalmic medical affairs and brand leadership experience to the Company. He joins TearLab from his current position as Senior Global Brand Lead, Global Medical Affairs at Alcon Laboratories Inc. ("Alcon"). In that role, he was responsible for strategic life cycle management, including post market studies, publications, KOL management and investigator initiated research for one of Alcon's largest device franchises, representing over $1 billion in annual revenue. Before joining Alcon in 2009, Dr. Venkiteshwar served as a Principal Research Scientist at Bausch & Lomb.Dr. Venkiteshwar is the author of over 50 scientific abstracts, research papers and book chapters. He is a member of a number of professional associations, including the American Academy of Optometry and the American Society of Cataract and Refractive Surgery, and is a reviewer for various professional publications, including Journal of Refractive Surgery, the American Journal of Ophthalmology, and the Journal of Cataract & Refractive Surgery. He received his BS in Optometry from Birla Institute of Technology and Science in India, and his MS and Ph.D. in Vision Science from the Ohio State University."I am really excited to be working with Manoj again," commented TearLab's President & COO, Seph Jensen. "His scientific accomplishments, broad professional network and successful experience at global ophthalmic industry leaders like Alcon and Bausch & Lomb will be a tremendous asset going forward as we work to enhance the way doctors interpret and use the number that the groundbreaking TearLab Osmolarity test provides."
27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.